Roche Holding AG (RHHBF)
OTCMKTS · Delayed Price · Currency is USD
483.97
-3.03 (-0.62%)
At close: Feb 19, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $378.54 billion as of February 20, 2026. Its market cap has increased by 49.36% in one year.
Market Cap
378.54B
Enterprise Value
406.65B
Revenue
79.90B
Ranking
n/a
PE Ratio
23.30
Stock Price
$483.97
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 378.54B, an increase of 4,221.92%. That is a compound annual growth rate of 11.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 378.54B | 14.18% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 791.42M |
| Veradigm | 765.06M |
| Glass House Brands | 651.19M |
| Northwest Biotherapeutics | 391.08M |
| American Oncology Network | 389.18M |
| Elite Pharmaceuticals | 387.58M |
| OpGen | 386.66M |
| CytoDyn | 330.55M |